Form 4: ClearPoint Neuro CEO Joseph Burnett Reports Stock Transactions
SEC Form 4 Filing
CEO Joseph Burnett of ClearPoint Neuro, Inc. reports the acquisition and disposal of common stock and restricted stock units on March 6, 2024.
Summary
- On March 6, 2024, Joseph Michael Burnett, CEO and President of ClearPoint Neuro, Inc., engaged in transactions involving the company's stock.
- Burnett acquired 23,704 shares of common stock through the vesting of restricted stock units.
- He also disposed of 11,066 shares to cover tax withholding obligations at a price of $6.24 per share.
- Following these transactions, Burnett directly owns 263,364 shares of ClearPoint Neuro common stock and 94,814 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, like the CEO, trades in their company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the CEO's holdings, but the overall impact is likely minimal as it relates to standard compensation practices.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of stock transactions: acquisition of 23,704 shares via restricted stock units and disposal of 11,066 shares for tax obligations. |
| 03/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.